Science and Technology

Overview

Our therapeutic targets include Acute Myeloid Leukemia (AML), Hodgkin’s Lymphoma (HL), Parkinson’s disease, and stroke. Our preliminary clinical studies indicated that RP-323, derived from croton oil of the plant Croton tiglium L. could modulate the differentiation of malignant cells via multiple molecular pathway at DNA level with respect to the above mentioned severe diseases. Our approach to alleviate these diseases is at the forefront of genomic medicine.

RP-323 MOLECULE

RP-323 is derived from the plant Croton tiglium L.

Croton-tiglium-L